Chronic Kidney Disease-Mineral-Bone Disorder: A New Paradigm

Sharon M. Moe, Tilman Drüeke, Norbert Lameire, Garabed Eknoyan

Research output: Contribution to journalArticle

158 Scopus citations

Abstract

Disturbances in mineral and bone metabolism are prevalent in chronic kidney disease (CKD) and an important cause of morbidity, decreased quality of life, and extraskeletal calcification that have been associated with increased cardiovascular mortality. These disturbances have traditionally been termed renal osteodystrophy and classified on the basis of bone biopsy. Kidney Disease: Improving Global Outcomes (KDIGO) recently sponsored a Controversies Conference to evaluate this definition. The recommendations were that (1) the term renal osteodystrophy be used exclusively to define alterations in bone morphology associated with CKD and (2) the term CKD-mineral and bone disorder (CKD-MBD) be used to describe the broader clinical syndrome that develops as a systemic disorder of mineral and bone metabolism as a result of CKD. CKD-MBD is manifested by an abnormality of any one or a combination of the following: laboratory-abnormalities of calcium, phosphorus, PTH, or vitamin D metabolism; bone-changes in bone turnover, mineralization, volume, linear growth, or strength; and calcification-vascular or other soft-tissue calcification. The pathogenesis and clinical manifestations of these components of CKD-MBD are described in detail in this issue of Advances in Chronic Kidney Disease.

Original languageEnglish (US)
Pages (from-to)3-12
Number of pages10
JournalAdvances in Chronic Kidney Disease
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2007

    Fingerprint

Keywords

  • calcium
  • CKD
  • mineral-bone bisorder
  • parathyroid hormone
  • phosphorus
  • renal osteodystrophy
  • vascular calcification
  • vitamin D

ASJC Scopus subject areas

  • Nephrology

Cite this